Eaton Vance Ohio Municipal Income Trust is a closed-end management investment company that primarily focuses on providing current income for investors through the acquisition and management of a diversified portfolio of municipal securities
These securities are predominantly issued by Ohio municipalities and are designed to generate tax-exempt income for investors. The Trust aims to offer a blend of capital appreciation and income through strategic investments, while also considering the potential impact of market interest rates and economic conditions on municipal debt. By focusing on Ohio-based issuers, the Trust seeks to capitalize on local market opportunities and provide value to its shareholders.
Halozyme offers to acquire Evotec for €11.00 per share, boosting Evotec's value to €2 billion. The merger aims to enhance Halozyme's revenue growth and portfolio.
Evotec and Novo Nordisk have partnered to develop off-the-shelf cell therapy products. The collaboration will focus on advancing stem cell-based therapies for potential commercialization.
Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges and outlines cost-cutting measures, including a 7% workforce reduction.
